Description
Anti-TNFRSF8 (Brentuximab-LC-R142) -DBCO-MMAF ADC | ADC-W-259 | Gentaur UK, US & Europe Distribution
Short Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (Brentuximab variant, LC-R142) conjugated via a DBCO linker to MMAF
Status: In stock
Expected Delivery Time: 9-11Weeks